• Publications
  • Influence
Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy.
BACKGROUND Patients who do not return for follow-up at clinics providing comprehensive HIV/AIDS care require special attention. This is particularly true where resources are limited and clinic loadsExpand
  • 167
  • 18
Gender Differences in Survival among Adult Patients Starting Antiretroviral Therapy in South Africa: A Multicentre Cohort Study
Morna Cornell and colleagues investigate differences in mortality for HIV-positive men and women on antiretroviral therapy in South Africa.
  • 194
  • 11
  • PDF
High Rates of Survival, Immune Reconstitution, and Virologic Suppression on Second-Line Antiretroviral Therapy in South Africa
To determine rates of survival, viral suppression, and immunologic change after 1 year on second-line antiretroviral therapy, we conducted a cohort study among 328 patients initiated on zidovudine,Expand
  • 90
  • 9
Loss to follow‐up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa
HIV‐positive pregnant women are at heightened risk of becoming lost to follow‐up (LTFU) from HIV care. We examined LTFU before and after delivery among pregnant women newly diagnosed with HIV.
  • 91
  • 9
  • PDF
Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir
Objective:In April 2010, the South African government added tenofovir disoproxil fumarate to its first-line antiretroviral therapy (ART) for HIV patients. We analyzed the relationship between renalExpand
  • 87
  • 8
Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa.
BACKGROUND The prevalence of HIV/hepatitis B virus (HBV) co-infection in South Africa ranges from 4.8% to 17% using the standard marker surface antigen (hepatitis B surface antigen, HBsAg) forExpand
  • 69
  • 8
  • PDF
A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects
BackgroundThere has been major improvement in the survival of HIV-1 infected individuals since the South African Government introduced highly active anti-retroviral therapy (HAART) in the publicExpand
  • 63
  • 8
Rates and Predictors of Failure of First-line Antiretroviral Therapy and Switch to Second-line ART in South Africa
Objectives: To measure rates and predictors of virologic failure and switch to second-line antiretroviral therapy (ART) in South Africa. Design: Observational cohort study. Methods: We includedExpand
  • 129
  • 7
  • PDF
Gender differences in mortality and CD4 count response among virally suppressed HIV-positive patients.
BACKGROUND Treatment outcomes for antiretroviral therapy (ART) patients may vary by gender, but estimates from current evidence may be confounded by disease stage and adherence. We investigated theExpand
  • 74
  • 7
Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa
Objectives:To compare outcomes of antiretroviral therapy (ART) in South Africa, where viral load monitoring is routine, with those in Malawi and Zambia, where monitoring is based on CD4 cell counts.Expand
  • 113
  • 6
  • PDF